Related Experiment Videos
WTO: failure to meet deadline on Doha commitments regarding access to generic drugs
Canadian HIV/AIDS Policy & Law Review
|August 20, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
High-throughput 3D phenotypic screening identifies repurposed MEK inhibitors as drivers of chondrogenesis for cartilage regeneration.
Frontiers in bioengineering and biotechnology·2026
Dyr726, a brain-penetrant inhibitor of PI3Kα, Type III receptor tyrosine kinases, and WNT signaling.
bioRxiv : the preprint server for biology·2025
Assessing options for poppers policy in Canada: A call to action for evidence-based policy reform.
The International journal on drug policy·2023
Treatment Action Campaign (TAC) v South Africa (Minister of Health): reflections on the right to health care in Canada.
Canadian HIV/AIDS policy & law review·2004
Australia: Supreme Court of Western Australia orders retrial in case of man convicted of infecting girlfriend with HIV.
Canadian HIV/AIDS policy & law review·2004
UK: Court of Appeal orders retrial in UK's first HIV criminal transmission case.
Canadian HIV/AIDS policy & law review·2004
Botswana: Industrial Court tackles HIV testing in the workplace.
Canadian HIV/AIDS policy & law review·2004
Australia: Migration Review Tribunal waives medical inadmissibility criteria for two HIV-positive visa applicants.
Canadian HIV/AIDS policy & law review·2004
US: immigration court allows Zambian woman's asylum claim based on HIV infection.
Canadian HIV/AIDS policy & law review·2004
Understanding non-medical prescribers' antimicrobial prescribing and stewardship competency: A scoping review.
Research in social & administrative pharmacy : RSAP·2026
False Friends in Fluorescence - Simple HPLC Evaluation of False Positive Fragment Hits in a DiFMUP Assay for Protein Tyrosine Phosphatase 1B.
Drug design, development and therapy·2026
Rebalancing innovation, affordability, and access for orphan drugs in the European Union.
The Lancet regional health. Europe·2026
Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.
Therapeutic innovation & regulatory science·2026